CytexOrtho

Honored to be featured in BONEZONE Magazine | OMTEC Expo alongside an incredible group of orthopedic innovators pushing the boundaries of orthopedic innovation: OrthoPreserve, Askel Healthcare Ltd, Foundation Surgical, ALLUMIN8, and VISIE Inc.! At CytexOrtho, we’re committed to solving one of orthopedics’ biggest challenges: helping young, active patients maintain their quality of life - without resorting to total joint replacement. As we gear up for our Phase I study, we’re excited for what 2025 has in store and remain focused on transforming the standard of care for patients facing hip disease. A huge thanks to BONEZONE Magazine | OMTEC Expo and Daniel Cook for highlighting our work! Read the full article here: 🔗 https://lnkd.in/erxHGENT #orthopedics #hip #clinicaltrials #medtech #regenerativemedicine #hipreplacement #hipresurfacing

CytexOrtho will be at the J.P. Morgan Healthcare Conference this year! We're dedicated to restoring joint function in active patients, and we're eager to connect with capital partners who share that vision. If you're attending the conference and would like to schedule a meeting, please reach out to Spencer Jones or our CEO, Brad Estes, Ph.D. We look forward to discussing the innovative solutions CytexOrtho is developing! #JPMorganHealthcare #HealthcareInnovation #InvestmentOpportunities #JointHealth

🚨 Today’s the Day! 🚨 Join us TODAY, December 4th, for our highly anticipated webinar on the future of hip surgery. 🕐 Don’t miss your chance to learn about the innovative ReNew™ Hip Implant System, its award-winning technology, and the exciting clinical trials that could change how we treat young patients with hip conditions. 📢 Featuring: Jeff Nepple, MD, Patrick Whitlock, MD, Thomas Vail, MD, and CytexOrtho’s founders: Farshid Guilak, PhD, Brad Estes, Ph.D., and Frank Moutos, PhD 📍 It’s not too late to register: https://lnkd.in/etGsiehA See you there! #hipresurfacing #hip #regenerativemedicine #orthopedics #AAOS #hippreservation

⏳ Time is running out! Only 2 days left to register for the American Academy of Orthopaedic Surgeons (AAOS) webinar on December 4th! Don't miss this opportunity to explore the future of hip surgery and the groundbreaking ReNew™ Hip Implant System. Join CytexOrtho and leading experts to learn about: ✅ Hip preservation strategies ✅ The innovative ReNew technology ✅ Upcoming clinical trials 📅 Register now before it’s too late! https://lnkd.in/etGsiehA #hipresurfacing #hip #regenerativemedicine #orthopedics #AAOS #hippreservation

📢Young patients are getting hip replacements at an alarming rate. Join our webinar on December 4th to learn about the future of hip surgery.   We’ll be diving into Hip Preservation and the groundbreaking ReNew™ Hip Implant System, presented by CytexOrtho in collaboration with leading experts: 👉 Jeff Nepple, MD 👉 Patrick Whitlock, MD 👉 Thomas Vail, MD   CytexOrtho's founders, Farshid Guilak, Ph.D., Brad Estes, Ph.D., and Frank Moutos, Ph.D., dive into the cutting-edge science behind the ReNew technology. Discover the innovation that won the inaugural OrthoPitch competition earlier this year in San Francisco and learn about upcoming clinical trials changing the game in hip preservation. Register now: https://lnkd.in/etGsiehA Don’t miss this opportunity to engage with the experts and explore the future of hip restoration! #hipresurfacing #hip #regenerativemedicine #orthopedics #AAOS #hippreservation

🚨Major Announcement🚨 CytexOrtho Receives FDA Approval for Revolutionary Hip Cartilage Repair Clinical Trial We're thrilled to announce that the FDA has approved our Investigational Device Exemption (IDE) application for the ReNew™ Hip Implant, clearing the path for our first-in-human clinical study. The ReNew Hip Implant represents a potential paradigm shift in the treatment of early stage osteoarthritis. Our bioabsorbable implant is designed to provide immediate structural support while promoting the body's natural healing process – offering hope for patients who are too young or active for traditional joint replacement. Thank you to our incredible team, partners, and supporters who have helped us reach this significant milestone. We look forward to beginning this important clinical study and working toward our mission of revolutionizing orthopedic care. 👉 Learn more about our technology and clinical trial: https://lnkd.in/e_tFEnmA #clinicaltrials #hip #cartilagerepair #regenerativemedicine #hipreplacement #hipresurfacing #venturecapital

CytexOrtho is honored to be part of MSK Innovations’ November 6th pitch event, showcasing groundbreaking technologies in musculoskeletal care! Our CEO and cofounder, Brad Estes, Ph.D., will present CytexOrtho's approach for treating early hip disease in a population with limited options. You'll also hear from Ofer Levy of ZygoFix Ltd., who will discuss their zLOCK system for spinal stabilization and Aditya Ingalhalikar, PhD, of INDIUS Medical Solutions, who will showcase their Patient Specific Growth Rods for pediatric scoliosis. 👉 You’re not going to want to miss this chance to hear about these exciting and innovative solutions. Register now: https://lnkd.in/gEP5fZzK #venturecapital #fundraising #orthopedics #orthopedicsurgery #medtech #hip #hippreservation

If you're passionate about cutting-edge musculoskeletal innovation, the Musculoskeletal New Ventures Conference (MNVC) is an event you can't miss. Gary Stevenson, Mike Sherman, and Chris Lyons have crafted an incredible agenda for this year, with a fantastic lineup of companies, and CytexOrtho is excited to be part of it once again! Let’s make this year’s event the best one yet! #orthopedics #hip #regenerativemedicine #innovation #investor #medicaldevice #medtech #2024MNVC

MSK Innovations is excited to announce our lineup for November 6th's Pitch Event! ZygoFix Ltd. - Ofer Levy, CEO ZygoFix has developed a proprietary approach to spinal stabilization and spinal fusion. The company's zLOCK system utilizes our spine’s natural anatomy for spinal stability. The system offers all around benefits to the $2.2 billion worldwide addressable spine market. CytexOrtho - Brad Estes, Ph.D., CEO CytexOrtho is developing an absorbable orthopedic implant designed to treat early hip disease in young/active patients, offering a much-needed solution for a growing population that currently lacks effective treatment options. INDIUS Medical Solutions - Aditya Ingalhalikar, PhD, CEO INDIUS has developed Patient Specific Growth Rods, an innovative solution for treating children with spinal scoliosis, reducing the need for multiple surgeries. INDIUS’s technology enables daily growth response, addressing a critical need in pediatric scoliosis care. The company holds global IP for this groundbreaking solution. Register today! https://lnkd.in/gEP5fZzK #venturecapital #seriesA #fundraising #orthopedics #orthopedicsurgery #scoliosis #medtech #spinesurgery Drue DeAngelis TJ Halvorson

A big thank you to North Carolina Biotechnology Center (NCBiotech) for inviting CytexOrtho to present at #TriangleVentureDay yesterday at the Raleigh Convention Center! Our CEO, Brad Estes, Ph.D., had the privilege of presenting our exciting preclinical data, and we were thrilled to share the progress we’re making in developing technologies to renew joints and restore the lives of those affected by arthritis at a young age. And congratulations to the NC Biotechnology Center on their incredible 40-year anniversary—here’s to many more years of advancing life sciences in North Carolina! #osteoarthritis #hip #innovation #startups #venturecapital #orthopedics #medtech #regenerativemedicine